Instruments

Name Stock exchange Average volume Price Type
PIERRE & VACANCES VAC

Euronext Paris +5 Other

264,662 1.548 EUR Stock Pierre & Vacances Stock
PIERRE & VACANCES PV6

Deutsche Boerse AG

- 1.52 EUR Stock Pierre & Vacances
PIERRE & VACANCES 0OQ0

London S.E.

9 1.575 EUR Stock Pierre & Vacances
PIERRE & VACANCES

LIQUIDNET SYSTEMS

- - EUR Stock Pierre & Vacances
PIERRE & VACANCES PV6

Börse Stuttgart

- 1.55 EUR Stock Pierre & Vacances
PIERRE & VACANCES PV6

BOERSE MUENCHEN

- 1.564 EUR Stock Pierre & Vacances
PIERRE AND VACANCES VACBT

Euronext Paris

0 0.3 EUR Warrant PIERRE AND VACANCES Warrant
PIERRE & 2.0/APR23 YVAC2

Euronext Paris

- - % Bond PIERRE & 2.0/APR23 Bond
PIERRE VACANCES BSA ACTIONNAIRES VACBS

Euronext Paris

0 0.14 EUR Warrant PIERRE VACANCES BSA ACTIONNAIRES Warrant
PIERRE VACANCES DS VACDS

Euronext Paris

- - EUR Stock PIERRE VACANCES DS Stock

News (760)

Idorsia announces changes to Idorsia Executive Committee and Board of Directors GL
Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA BU
Ono Pharmaceutical : Receives Approvals of BRAFTOVI® and MEKTOVI® for Expanded Use for Two New Indications in Japan PU
Laboratory of America : Labcorp Announces Retirement of Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard from Its Board of Directors PU
Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress BU
Togo votes amid tensions over constitutional reform RE
Laboratory of America : Corporate Responsibility Report (Labcorp_Corporate_Responsibility_Report_2023_Final_v3_1) PU
Laboratory of America : Corporate Responsibility Report (Labcorp_Corporate_Responsibility_Report_2023_Final_v3_2) PU
Laboratory of America : 2023 Corporate Responsibility Report PU
XOMA Corporation Announces Closing of Tender Offer AQ
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress BU
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease GL
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease AQ
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories AQ
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories PR
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories AQ
Pfizer : Oncology Innovation Day Presentation PU
Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology BU
Atara Biotherapeutics, Inc. and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel®? Data in The Lancet Oncology CI
Transcript : Elis SA, 2023 Sales/ Trading Statement Call, Jan 30, 2024
Transcript : Atara Biotherapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09:45 AM
Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference BU
Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer GL
Acrivon Therapeutics, Inc. Announces Management Changes CI
Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories BU
Atara Biotherapeutics, Inc. Announces Closing of Expanded Global Tab-Cel Partnership with Pierre Fabre Laboratories CI
Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis BU
Atara Biotherapeutics, Inc. Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis CI
ATARA BIOTHERAPEUTICS ANNOUNCES EXPANDED GLOBAL TAB-CEL PARTNERSHIP WITH PIERRE FABRE LABORATORIES AND THIRD QUARTER 2023 FINANCIAL RESULTS AQ
Transcript : Atara Biotherapeutics, Inc., Q3 2023 Earnings Call, Nov 01, 2023
Atara Biotherapeutics : Investor Presentation PU
Atara Biotherapeutics Announces Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results BU
Atara Biotherapeutics, Inc. Announces Expanded Global Tab-Cel Partnership with Pierre Fabre Laboratories CI
Immutep : ESMO 2023 - EFTISARC-NEO Trial in Progress Poster (Soft Tissue Sarcoma) PU
DBV Technologies S.A. Announces Executive Changes CI
DBV Technologies S.A. Appoints Virginie Boucinha as Principal Accounting Officer, Effective as of November 6, 2023 CI
DBV Technologies appoints new CFO CF
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer GL
U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer BU
U.S. FDA Approves Pfizer?s Braftovi® + Mektovi® for Braf V600e-Mutant Metastatic Non-Small Cell Lung Cancer CI
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology AQ
ATARA BIOTHERAPEUTICS ANNOUNCES PLANS TO SUBMIT TAB-CEL BLA IN Q2 2024 FOLLOWING FDA AGREEMENT ON COMPARABILITY AQ
Atara Biotherapeutics Announces Plans to Submit Tab-cel® BLA in Q2 2024 Following FDA Agreement on Comparability BU
Transcript : Atara Biotherapeutics, Inc. Presents at Citi 18th Annual BioPharma Conference, Sep-07-2023 01:50 PM
Transcript : Gracell Biotechnologies Inc. Presents at Citi 18th Annual BioPharma Conference, Sep-07-2023 01:50 PM
1234NextSee all

Companies (25)

BIOPHARM - $
Logo BIOPHARM

Biopharm SPA is one of the leading pharmaceutical groups in Algeria. The group manufactures generic pharmaceuticals under its own brands, as well as licensed drugs for laboratories such as Sanofi, Eli Lilly and Pierre Fabre. At the end of 2022, Biopharm ...

GALENICA AG 3 872 M $
Logo Galenica AG

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established ...

NETMEDIA GROUP 10 M $
Logo NetMedia Group

NetMedia Group is one of the leading independent players in the BtoB communications, marketing and media market in France. The Group is organized around three synergistic areas of expertise: - Consulting: with 3 branches to support companies in defining ...

TRES-OR RESOURCES LTD. 2 M $
Logo Tres-Or Resources Ltd.

Tres-Or Resources Ltd. is a Canada-based resource company. The Company is engaged in the acquisition and development of exploration and evaluation assets in Canada. The Company is focused on exploring for diamonds and gold resources in the Temiscamingue a ...

GO METALS CORP. 2 M $
Logo Go Metals Corp.

Go Metals Corp. is a Canada-based exploration stage company. The HSP Nickel-Copper-Cobalt Project is located approximately 130 kilometers (km) north of Havre-Saint-Pierre in Quebec and approximately 150 square kilometers property is located within the Gre ...

PIERRE & VACANCES 764 M $
Logo Pierre & Vacances

Pierre & Vacances is a leading European operator of tourist residences and villages. Net sales break down by a ctivity as follows: - operation of residences and villages (94.5%): manages, at the end of September 2023, a total of 45,866 apartments and ho ...

IMMOBILIÈRE PARISIENNE DE LA PERLE ET DES PIERRES PRÉCIEUSES 1 M $
Logo Immobilière Parisienne de la Perle et des Pierres Précieuses

Immobilière Parisienne de la Perle et des Pierres Précieuses specializes in holding and managing of the building located at 38 rue Croix des Petits Champs and the building located at Avenida Nicolas de Pierola n°508-540, Esquina con la Avenida Garcilaso d ...

SINCERE WATCH (HONG KONG) LIMITED 14 M $
Logo Sincere Watch (Hong Kong) Limited

Sincere Watch (Hong Kong) Limited is a Hong Kong-based investment holding company principally engaged in watch businesses. The main businesses of the Company include the distribution of branded watches, timepieces and accessories, dining businesses and pr ...

TRUWORTHS LIMITED - $
Logo Truworths Limited

Truworths Limited specializes in the design, manufacturing and marketing of clothes and accessories for men and women. Net sales break down by activity as follows: - retail distribution of clothes and accessories (98.6%): Nine West, Guess, Ka'yanda, Bert ...

AHLERS AG 163 405 $
Logo Ahlers AG

Ahlers AG is a Germany-based manufacturer of fashion products. It operates through two segments: Premium Brands and Jeans, Casual & Workwear. The Premium Brands segment comprises the Baldessarini, Pierre Cardin and Otto Kern brands, and provides clothes f ...


123Next

Insiders





Picture François Fabre
François Fabre

François Fabre currently works as a Director at Vallourec & Mannesmann Tubes SA.


Picture Ernie Fabre
Ernie Fabre

Ernie Fabre worked as a Marketing Director at Intelligent Software Solutions Corp.



Picture Andrés Fabre
Andrés Fabre

Andrés Fabre currently works as a Director of Operations at Aerotransportes Más de Carga SA de CV.



No results for this search

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW